powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1093072548
Li Song
Endocrinology
Dallas,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 450015
Hospital
CCN 450021
Hospital
CCN 450044
Hospital
CCN 450079
Hospital
CCN 450651
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,161
Beneficiaries
—
Total drug cost
$443K
Distinct drugs
15
Brand share
18.6%
Top prescribed drugs
Alendronate Sodium
549 claims
Teriparatide
91 claims
Potassium Citrate
58 claims
Indapamide
55 claims
Pen Needle, Diabetic
52 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
500
Unique beneficiaries
—
Total services
513
Distinct HCPCS
5
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 484 Endocrinology providers in TX — below median (cohort median 868).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$70
Payment records
3
By payment type
Food and Beverage
$70
Top paying entities
Food and Beverage
$70
QUALITY · MIPS · 2024
Final MIPS score
82.9
Quality
70.2
Cost
72.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.33%
Group
